colonMSM {markovMSM} | R Documentation |
Chemotherapy for Stage B/C colon cancer.
Description
These are data from one of the first successful trials of adjuvant chemotherapy for colon cancer. Levamisole is a low-toxicity compound previously used to treat worm infestations in animals; 5-FU is a moderately toxic (as these things go) chemotherapy agent.
Usage
data("colonMSM")
Format
A data frame with 929 observations on the following 15 variables. Below a brief description is given for some of these variables.
- time1
Time to recurrence/censoring/death, whichever occurs first.
- event1
Recurrence/censoring indicator (recurrence=1, alive=0).
- Stime
Time to censoring/death, whichever occurs first.
- event
Death/censoring indicator (death=1, alive=0).
- rx
Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU.
- sex
Sex indicator (male=1, female=0).
- age
Age in years.
- obstruct
Obstruction of colon by tumour.
- perfor
Perforation of colon.
- adhere
Adherence to nearby organs.
- nodes
Number of lymph nodes with detectable cancer.
- differ
Differentiation of tumour (1=well, 2=moderate, 3=poor).
- extent
Extent of local spread (1=submucosa, 2=muscle, 3=serosa, 4=contiguous structures).
- surg
Time from surgery to registration (0=short, 1=long).
- node4
More than 4 positive lymph nodes.
Source
The study is originally described in Laurie (1989).The main report is found in Moertel (1990). This data set is closest to that of the final report in Moertel (1991). A version of the data with less follow-up time was used in the paper by Lin (1994).
References
JA Laurie, CG Moertel, TR Fleming, HS Wieand, JE Leigh, J Rubin, GW McCormack, JB Gerstner, JE Krook and J Malliard. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil: The North Central Cancer Treatment Group and the Mayo Clinic. Journal of Clinical Oncology, 7:1447-1456, 1989.
DY Lin. Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine, 13:2233-2247, 1994.
CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, PJ Goodman, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New England Journal of Medicine, 332:352-358, 1990.
CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, CM Tangen, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. Fluorouracil plus Levamisole as and effective adjuvant therapy after resection of stage II colon carcinoma: a final report. Annals of Internal Medicine, 122:321-326, 1991.
Examples
data(colonMSM)
head(colonMSM)